Merck Group

MerckMerck KGaABritish Drug HousesE. MerckE. Merck & Co.E. Merck DarmstadtEmanuel MerckEMDEMD ChemicalsEMD Pharmaceuticals
Merck KGaA (also called as the Merck Group), branded and commonly known as Merck, is a German multinational pharmaceutical, chemical and life sciences company headquartered in Darmstadt, with about 56,000 employees and present in 66 countries.wikipedia
307 Related Articles

Morphine

morphiamorphine addictionmorphine sulfate
Merck pioneered the commercial manufacture of morphine in the 19th century and for a time held a virtual monopoly on cocaine.
Merck began marketing it commercially in 1827.

Merck family

Merck
The Merck family still controls a majority 70.3% of the company's shares.
The Merck family is a German family of industrialists and bankers, known for establishing the world's oldest pharmaceutical company Merck, its American former subsidiary Merck & Co. (MSD), which is now an independent company, as well as the Hamburg merchant bank H. J. Merck & Co. The family still owns the majority of the pharmaceutical company Merck.

Merck & Co.

MerckMerck & CoMerck & Co., Inc.
The American pharmaceutical company Merck & Co. was established as a subsidiary of Merck in 1891, but was nationalized by the United States in 1917, before being privatized again when George W. Merck purchased back the stock in 1919.
The company was established in 1891 as the United States subsidiary of the German company Merck, which was founded in 1668 by the Merck family.

Darmstadt

Darmstadt, GermanyHessen-DarmstadtDA
Merck KGaA (also called as the Merck Group), branded and commonly known as Merck, is a German multinational pharmaceutical, chemical and life sciences company headquartered in Darmstadt, with about 56,000 employees and present in 66 countries. In 1668, Friedrich Jacob Merck, an apothecary, assumed ownership of the Engel-Apotheke ("Angel Pharmacy") in Darmstadt, Germany.
Darmstadt is also the seat of the world's oldest pharmaceutical company, Merck, which is the city's largest employer.

Merck Millipore

Millipore CorporationMilliporeEMD Millipore
In 2010 Merck took over Billerica (MA) based Millipore Corporation for EUR 5.3 billion (US$7.2 billion).
Merck Millipore was the brand used for Merck's global life science business until 2015 when the company re-branded.

Technische Universität Darmstadt

Darmstadt University of TechnologyTechnical University of DarmstadtTechnische Hochschule Darmstadt
Merck has formed a strategic alliance with the Technische Universität Darmstadt, which is located in the same town as Merck.
The TU Darmstadt maintains strategic alliances with the companies Merck, Deutsche Bahn, Continental, Robert Bosch GmbH and Siemens.

Merck Serono

EMD SeronoMerckMerck-Serono
The new entity, Merck Serono, began operations in 2007.
Merck Serono (EMD Serono in the United States and Canada) is a pharmaceutical company headquartered in Darmstadt, Germany, and a brand and division of Merck focused on biopharmaceuticals.

Serono

Merck SeronoPiero DoniniSerono International S.A.
In September 2006 the company announced a takeover bid of $13.2 billion for Serono SA, Switzerland's largest biotech firm.
It was acquired by the German pharmaceutical company Merck in 2006.

DAX

DAX ComponentDAX 30Xetra DAX
Merck was privately owned until going public on the Frankfurt Stock Exchange in 1995, and is listed on the DAX index of Germany's top companies.

Sigma-Aldrich

Sigma AldrichSigma-Aldrich CorporationAldrich
Later in September it was announced that the company would acquire Sigma-Aldrich for $17 billion.
Sigma-Aldrich Corporation is an American chemical, life science and biotechnology company owned by Merck KGaA.

AZ Electronic Materials

In December 2013, the company bought AZ Electronic Materials SA (AZEM) for about $2.6 billion in cash to increase its offering of specialty chemicals to the electronics industry.
On 2 May 2014, Merck KGaA announced the successful acquisition of AZ Electronic Materials.

Ernesto Bertarelli

ErnestoBertarelliBertarelli Foundation
The deal included a buy-out of the Bertarelli family's 64.5% stake in Serono to be followed by a public tender offer for the remaining shares starting in November 2006.
Bertarelli and his family sold the company to Merck KGaA of Germany in January 2007 for US$13.3 billion, forming the new company Merck-Serono.

Karl-Ludwig Kley

In October, it was announced that Karl-Ludwig Kley, CEO of Merck since April 2007, would retire in April 2016, and be succeeded by Stefan Oschmann, who has been a member of the executive board since 2011.
Karl-Ludwig Kley (born 11 June 1951 in Munich) is a German business executive, and was the chief executive officer (CEO) and chairman of the executive board of the German multinational chemical, pharmaceutical and life sciences company Merck.

Tecemotide

Stimuvax
One drug candidate suffered a lack of success in patient recruitment, with its MUC1 antigen-specific cancer immunotherapy drug, tecemotide (L-BLP25), missing its Phase I/II endpoint of increasing overall survival in patients with Stage III non-small cell lung cancer.
In 2001, Merck KGaA, Darmstadt, Germany, entered into a collaboration and supply agreement with Oncothyreon.

Stefan Oschmann

In October, it was announced that Karl-Ludwig Kley, CEO of Merck since April 2007, would retire in April 2016, and be succeeded by Stefan Oschmann, who has been a member of the executive board since 2011.
Stefan Oschmann (born 25 July 1957) is a German businessman, who has served as the chief executive officer (CEO) and chairman of the executive board of the Germany-based Merck Group since April 2016.

Mylan

Mylan N.V.Mylan PharmaceuticalsMylan Inc.
In April 2018, Reuters reported that generic drug manufacturer, Mylan was in advanced discussions to acquire the consumer health business for between €3.5–4 billion (£3–3.4 billion).
In 2007, Mylan acquired a controlling interest in India-based Matrix Laboratories Limited, a top producer of active pharmaceutical ingredients (APIs) for generic drugs, and the generics business of Germany-based Merck KGaA.

Schering AG

ScheringSchering OySchering-Kahlbaum
On March 13, 2006, Merck announced a takeover bid for Schering AG, the world's largest producer of oral contraceptives.
In March 2006, Merck KGaA announced a €14.6bn bid for Schering, which by 2006 had annual gross revenue of around €5 billion and employed about 26,000 people in 140 subsidiaries worldwide.

Pfizer

Pfizer Inc.Pfizer, Inc.Pfizer Inc
In November 2014, Merck and Pfizer agreed a deal for the latter to sell the former sharing rights to develop an experimental immunotherapy drug for a fee of $850 million.
Hopes for a renewed bid later in the year were dashed when Pfizer signed a major cancer drug deal with Merck KGaA, selling its sharing rights to develop an experimental immunotherapy drug for a fee of $850 million.

Billerica, Massachusetts

BillericaBillerica, MANutting Lake
In 2010 Merck took over Billerica (MA) based Millipore Corporation for EUR 5.3 billion (US$7.2 billion).

Bayer

Bayer AGBayer CropScienceBayer HealthCare
On March 23, 2006, Bayer AG made a supported offer for Schering and Merck decided to drop out of the bidding for the company.
In March 2006 Merck KGaA announced a €14.6bn bid for Schering AG, founded in 1851.

Procter & Gamble

Procter and GambleP&GProcter & Gamble Productions
Later in the month, Reuters reported that Procter & Gamble would purchase the division for €3.4 billion euros (£2.96 billion; $4.2 billion).
In April 2018, Reuters reported that Procter & Gamble would purchase the consumer health division of Merck Group (known as EMD Serono in North America) for €3.4 billion (£2.96 billion; $3.9 billion).

Friedrich Jacob Merck

In 1668, Friedrich Jacob Merck, an apothecary, assumed ownership of the Engel-Apotheke ("Angel Pharmacy") in Darmstadt, Germany.
He was the founder of the world’s oldest pharmaceutical company, Merck KGaA, which was established in 1668.

Versum Materials

Versum Materials Inc
In April 2019, Merck announced it would acquire Versum Materials for $6.5 billion ($53-per-share).
It is a subsidiary of Merck Group.

Cetuximab

Erbitux
In the former therapeutic area, its first marketed product is Erbitux (cetuximab), for which it has marketing rights worldwide, apart from North America.
Cetuximab is a chimeric (mouse/human) monoclonal antibody given by intravenous infusion that is distributed under the trade name Erbitux in the U.S. and Canada by the drug company Eli Lilly and Co. and outside those countries by the drug company Merck KGaA.

Xirallic

An example for these pigments are alumina effect pigments sold under brand name Xirallic ®.
It was developed and patented by researchers of the company Merck KGaA in Japan.